Vector VestAdvertisement
Home > Boards > US OTC > Biotechs >

MedClean Technologies, Inc. (MCLN)

Add MCLN Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 1/22/2015 12:24:17 PM - Followers: 259 - Board type: Free - Posts Today: 0


MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. 


(Click on link below to view a must see video.)

MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract

Thu Mar 26, 2009 8:00am EDT 


MedClean to Offer RMW Solutions to MedAssets' GPO Customer Hospitals


MedAssets (Nasdaq: MDAS) partners with healthcare providers to improve their 

financial strength by implementing integrated spend management and revenue

cycle solutions that help control cost, improve margins and cash flow,

increase regulatory compliance, and optimize operational efficiency. MedAssets

serves more than 125 health systems, 3,300 hospitals and 30,000 non-acute care

healthcare providers.

(MedAssets Trades on the NASDAQ as MDAS at over $20.00+ per share.)

MedClean Technologies, Inc. Approved in New Jersey

Garden State Hospitals Can Now Enjoy MedClean Guaranteed Saving Program

Approval Follows Joint Authorization Process by NJ Department of Environmental
Protection and NJ Department of Health and Senior Services




Part 1


Part 2










MedClean Technologies sets the standard for efficacy testing and validation through an ongoing commitment that has resulted in the most extensive body of work in the industry. The MedClean System meets and exceeds the most demanding standards throughout all 50 states. Our work in this area has yielded a protocol that includes significant proprietary intellectual property and is the subject of a United States patent. All MedClean efficacy testing and protocol development is conducted using actual RMW from healthcare institutions to mirror real world operations.

MedClean Technologies is committed to ongoing research and development in this area and to close collaboration with industry experts to provide continuous enhancement of its Best Practices. 

System Components 






 Medcleantechnologies, Inc. Partnerships: style="font-size: medium;">





Per Yahoo & SEC Filings:

Outstanding Shares (OS) = 809,743,450  as of Dec 2010

Restricted Shares = 293.43

Float = 588.34M 

Authorized Shares (AS) = 3.5B



Management Team



Jay S. Bendis

Chairman of the Board of Directors

Mr. Bendis was appointed as Chairman of the Board of the Company effective March 31, 2011. Mr. Bendis has been President of Transfer Technology Consultants during the past 20 years specializing in transferring emerging life science product concepts from design to commercialization in both domestic and international markets. He was President and CEO of Clinical Analysis Corp., which has developed a hand-held diagnostic system for patient point-of-care testing. He was Managing Partner in the Crystal Corridor Group which worked with Kent State University's Liquid Crystal Institute in facilitating liquid crystal technology. He was Executive Vice President of American BioMedica Corp, which develops, manufacturers and markets immunoassay diagnostic test kits for the workplace, correctional and clinical markets. He was President and Co-founder of Emerging Technology Systems which is a research and development company consisting of engineers specializing in developing new medical devices. His prior management positions had been with XANAR Laser Corp, a division of Johnson & Johnson as the National Sales Manager and Sales and Marketing Manager for the IVAC Corp., a division of Eli Lilly and had sales and management experience with XEROX. He was also a member of the Edison BioTechnology Center Advisory Council for the State of Ohio and presently serves on the Board of Directors of several privately and publicly held companies.



David J. Laky

President and Chief Executive Officer

Mr. Laky was appointed to the positions of President and Chief Executive Officer of the Company effective November 9, 2009. Prior to such appointment Mr. Laky was the Company's Senior Vice President of Client Services and Technology since September 2008. Mr. Laky joined the Company from eResearch Technology, Inc. where from 2005 to 2008 he was General Manager & Vice President of eClinical Group. He served eRT as VP of Professional Services from 1999 to 2005.




Cheryl K. Sadowski

Chief Financial Officer

Ms. Sadowski was appointed to the positions of Chief Financial Officer of the Company effective August 4, 2009. Prior to such appointment Ms. Sadowski was the Company's Vice-President and Controller since October 2008. From February 1994 until October 2008 she held several positions at eResearchTechnology, Inc. in Bridgewater, New Jersey, including Vice President, Business Management and Senior Director, Business Management, where she was responsible for budgeting, forecasting, financial systems and analysis for the Professional Services, Project Management, Customer Care, Research & Development, IT and Cardiac Safety Divisions. She also handled the facilities management and administration for the Bridgewater office.




John R. Accardi

Senior Vice President of Sales/Business Development

Mr. Accardi was named Senior Vice President of Sales/Business Development in September, 2008. Prior, he was with Oracle Corporation/Siebel Systems, where he was responsible for a $40 million line of business and led sales efforts for the financial services and insurance markets in the southeast region and, earlier, served as Senior Director of Siebel's North American Reseller Network. Previously, he served as Vice President of Worldwide Sales for Rasterex, a global provider of software and services extending the value of Auto-Cad solutions. At Rasterex, Mr. Accardi drove $15 million in first year revenue and reversed an operating loss to a profit during the same period. Previously, he served in executive management capacities at systems integrator Gary Brown & Associates and applications provider Computron Software, Inc., Ross Systems and WANG Laboratories.





MCLN Contact Info

MedClean Technologies, Inc
3 Trowbridge Drive
Bethel, CT 06801
Phone: 203-798-1080
Fax: 203-798-0147
Web Site:




Daily View


Weekly View





  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#35091   Any time frame for fins? ASK 01/22/15 12:24:17 PM
#35090   There is little at the Ask and this Bansky 01/22/15 11:52:35 AM
#35089   Interesting a couple of $100 dollars at the xuejia 01/22/15 10:57:02 AM
#35088   Yes, a super 8K with audited financials after Bansky 01/20/15 05:13:36 PM
#35087   Thx Bansky, Should they not have to xuejia 01/20/15 01:57:44 PM
#35086   They tried to do a merger with another Bansky 01/20/15 01:38:42 PM
#35085   Hi all, new to this board. Why xuejia 01/20/15 12:58:57 PM
#35084   141k market cap. Lets hope John pack10 01/20/15 10:01:26 AM
#35083   23 million outstanding with much in float. I Bansky 01/20/15 07:36:35 AM
#35082   Do you know what the current float is? pack10 01/19/15 09:25:48 AM
#35081   Any time frame for RM or at least ASK 01/16/15 11:52:35 PM
#35080   The company has no money to even do Bansky 01/16/15 09:49:39 PM
#35079   Yes. Many filings due. New management. IMO, several Bansky 01/16/15 07:26:14 AM
#35078   Are we close to see some fillings? ASK 01/15/15 06:05:10 PM
#35077   i had to buy at the ask over launch3 01/15/15 11:50:33 AM
#35076   You could have bought all you wanted to Bansky 01/15/15 11:04:09 AM
#35075   The stock has a low float and therefore Bansky 01/14/15 06:00:38 PM
#35074   Agree. PPS will go above 2 cents only with fillings. ASK 01/14/15 04:13:37 PM
#35073   After the delinquent financials are filed you will Bansky 01/14/15 01:23:39 PM
#35072   I'm just waiting patiently. Been here so long, launch3 01/13/15 04:00:43 PM
#35071   I believe if something was going on we'd pack10 01/13/15 03:27:43 PM
#35070   Smart move to have bought again at cheap Bansky 12/31/14 04:51:46 PM
#35069   Exciting stuff. John actually emailed me back for launch3 12/31/14 04:47:28 PM
#35068   Excellent. I take that price. ASK 12/31/14 03:33:41 PM
#35067   Now that I have bought alot of paper Bansky 12/31/14 03:31:33 PM
#35066   Hmmmmm Green Harvester 12/31/14 03:16:19 PM
#35065   Volume spike. ASK 12/31/14 02:33:16 PM
#35064   Good risk here and good buy at W***too. Bansky 12/23/14 06:04:03 PM
#35063   no joke. MM's have been here for over launch3 12/18/14 03:03:44 PM
#35062   Is this a joke??? fogao 2012 12/18/14 12:43:01 PM
#35061   Thin stock. ASK 12/17/14 12:27:09 PM
#35060   Ok, thanks for the reply. Will keep pack10 12/12/14 07:57:39 PM
#35059   Hearing some deals on John Accardi's table. ASK 12/12/14 05:25:29 PM
#35058   Just a question, what do these guys have pack10 12/12/14 04:42:13 PM
#35057   I want to add more during this tax ASK 12/12/14 04:15:54 PM
#35056   Got 100k more at end of day. Couldn't launch3 12/12/14 04:09:43 PM
#35055   Added 75K today. ASK 12/12/14 03:59:34 PM
#35054   Definitely doesn't pay to sell for anyone here launch3 12/11/14 01:01:00 PM
#35053   If my guess is right he'll hang on pack10 12/11/14 12:45:15 PM
#35052   If ttxxhorns is even selling some, i figured launch3 12/11/14 12:38:38 PM
#35051   I don't know what it costs to file pack10 12/11/14 12:25:28 PM
#35050   All is quiet here. Nobody is budging on launch3 12/11/14 11:47:01 AM
#35049   OK Thx I just have sent an email. ASK 12/05/14 11:40:29 AM
#35048   No, unfortunately. His email is Phone number launch3 12/05/14 11:31:05 AM
#35047   Do you have his cell or contact number? ASK 12/05/14 11:19:03 AM
#35046   I've corresponded with Accardi in the past. launch3 12/05/14 11:18:01 AM
#35045   I think fillings coming end of Dec. ASK 12/05/14 11:07:12 AM
#35044   Bought more. Lowered my breakeven point by a lot. launch3 12/05/14 11:04:39 AM
#35043   Big habit of the MMs pack10 12/05/14 10:05:42 AM
#35042   someone keeps buying at the bid at .25 launch3 12/05/14 09:53:54 AM